These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma. Sobral LM; Hicks HM; Parrish JK; McCann TS; Hsieh J; Goodspeed A; Costello JC; Black JC; Jedlicka P Mol Oncol; 2020 Oct; 14(10):2471-2486. PubMed ID: 32697014 [TBL] [Abstract][Full Text] [Related]
9. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416 [TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts. Ghayad SE; Rammal G; Ghamloush F; Basma H; Nasr R; Diab-Assaf M; Chelala C; Saab R Sci Rep; 2016 Nov; 6():37088. PubMed ID: 27853183 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma. Nguyen TH; Barr FG Molecules; 2018 Oct; 23(11):. PubMed ID: 30373318 [TBL] [Abstract][Full Text] [Related]
13. Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling. Rammal G; Fahs A; Kobeissy F; Mechref Y; Zhao J; Zhu R; Diab-Assaf M; Saab R; Ghayad SE J Proteome Res; 2019 Oct; 18(10):3567-3579. PubMed ID: 31448612 [TBL] [Abstract][Full Text] [Related]
14. The RNA helicase DDX5 cooperates with EHMT2 to sustain alveolar rhabdomyosarcoma growth. Gualtieri A; Bianconi V; Renzini A; Pieroni L; Licursi V; Mozzetta C Cell Rep; 2022 Aug; 40(9):111267. PubMed ID: 36044855 [TBL] [Abstract][Full Text] [Related]
15. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Linardic CM Cancer Lett; 2008 Oct; 270(1):10-8. PubMed ID: 18457914 [TBL] [Abstract][Full Text] [Related]
16. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors. de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386 [TBL] [Abstract][Full Text] [Related]
17. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells. De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362 [TBL] [Abstract][Full Text] [Related]
18. FAK Signaling in Rhabdomyosarcoma. Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556 [TBL] [Abstract][Full Text] [Related]
19. A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target. Boudjadi S; Pandey PR; Chatterjee B; Nguyen TH; Sun W; Barr FG Cancer Res; 2021 Jun; 81(11):2930-2942. PubMed ID: 33589519 [TBL] [Abstract][Full Text] [Related]
20. Negative correlation of single-cell Regina C; Hamed E; Andrieux G; Angenendt S; Schneider M; Ku M; Follo M; Wachtel M; Ke E; Kikuchi K; Henssen AG; Schäfer BW; Boerries M; Wagers AJ; Keller C; Hettmer S Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34187933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]